Bruce Car

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

BHVN

Current role

AGIO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Biohaven Ltd. (BHVN)	Chief Scientific Officer	$515,567	$451,121	—	$2,945,471	—	$22,919	$3,935,078
2023	Biohaven Ltd. (BHVN)	Chief Scientific Officer	$489,850	$385,757	—	$1,701,221	—	$7,420	$2,584,248
2022	Agios Pharmaceuticals, Inc. (AGIO)	Former Chief Scientific Officer	$309,429	—	$370,300	$707,400	—	$465,255	$1,852,384
2022	Biohaven Ltd. (BHVN)	Chief Scientific Officer	$121,250	$160,100	—	$1,490,771	—	$1,787	$1,773,908
2021	Agios Pharmaceuticals, Inc. (AGIO)	Former Chief Scientific Officer	$515,000	—	$623,480	$1,404,373	$254,926	$6,194	$2,803,973
2020	Agios Pharmaceuticals, Inc. (AGIO)	Former Chief Scientific Officer	$494,318	—	$833,301	$1,499,943	$236,250	$164,231	$3,228,043
2019	Agios Pharmaceuticals, Inc. (AGIO)	Chief Scientific Officer	—	—	—	—	—	—	—
2018	Agios Pharmaceuticals, Inc. (AGIO)	Chief Scientific Officer	—	—	—	—	—	—	—

No earnings-call appearances or filed executive changes recorded yet.